search Created with Sketch.
search Created with Sketch.

Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

Derms Fight MOC; Cipher Buys Innocutis

The AAD asks the American Board of Dermatology for changes to Maintenance of Certification (MOC) requirements; Jeanine Downie, MD and Heidi Waldorf, MD discuss problems with current and proposed requirements. Galderma presents data to support new investigational adapalene 0.3%/benzoyl peroxide 2.5% formulation. Cipher acquires Innocutis, maker of HSV therapy Sitavig.

Advertisement

In This Series

View More

Advertisement